Black Diamond Therapeutics (BDTX)

• Market cap: $225M
• 1 day: 0.51%
• 5 days: -3.66%
• 1 month: 5.9%
• 3 months: 34.81%
• 6 months: 146.88%
• Year to date: 84.58%
• 1 year: 35.27%
• 5 years: -87.93%
• 10 years: -89.99%
• Sector: Healthcare
• Industry: Biotechnology

About: Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Employees: 54